Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 44

1.

Altered synaptic plasticity in a mouse model of fragile X mental retardation.

Huber KM, Gallagher SM, Warren ST, Bear MF.

Proc Natl Acad Sci U S A. 2002 May 28;99(11):7746-50.

2.

Functions of the fragile X protein.

Oostra BA.

Trends Mol Med. 2002 Mar;8(3):102-3. No abstract available.

PMID:
11879765
3.

Alterations in the auditory startle response in Fmr1 targeted mutant mouse models of fragile X syndrome.

Nielsen DM, Derber WJ, McClellan DA, Crnic LS.

Brain Res. 2002 Feb 8;927(1):8-17.

PMID:
11814427
4.

Local and global cerebral blood flow and glucose utilization in the alpha-galactosidase A knockout mouse model of Fabry disease.

Itoh Y, Esaki T, Cook M, Qasba P, Shimoji K, Alroy J, Brady RO, Sokoloff L, Moore DF.

J Neurochem. 2001 Dec;79(6):1217-24.

5.

The fragile X mental retardation protein inhibits translation via interacting with mRNA.

Li Z, Zhang Y, Ku L, Wilkinson KD, Warren ST, Feng Y.

Nucleic Acids Res. 2001 Jun 1;29(11):2276-83.

6.

Estimation of the number of "true" null hypotheses in multivariate analysis of neuroimaging data.

Turkheimer FE, Smith CB, Schmidt K.

Neuroimage. 2001 May;13(5):920-30.

PMID:
11304087
7.

Fragile X mice develop sensory hyperreactivity to auditory stimuli.

Chen L, Toth M.

Neuroscience. 2001;103(4):1043-50.

PMID:
11301211
8.

Evidence that fragile X mental retardation protein is a negative regulator of translation.

Laggerbauer B, Ostareck D, Keidel EM, Ostareck-Lederer A, Fischer U.

Hum Mol Genet. 2001 Feb 15;10(4):329-38.

9.

Spatial learning, contextual fear conditioning and conditioned emotional response in Fmr1 knockout mice.

Van Dam D, D'Hooge R, Hauben E, Reyniers E, Gantois I, Bakker CE, Oostra BA, Kooy RF, De Deyn PP.

Behav Brain Res. 2000 Dec 20;117(1-2):127-36. Erratum in: Behav Brain Res 2001 Nov 29;126(1-2):219.

PMID:
11099766
10.

Fmr1 knockout mouse has a distinctive strain-specific learning impairment.

Dobkin C, Rabe A, Dumas R, El Idrissi A, Haubenstock H, Brown WT.

Neuroscience. 2000;100(2):423-9.

PMID:
11008180
11.

Dendritic spine structural anomalies in fragile-X mental retardation syndrome.

Irwin SA, Galvez R, Greenough WT.

Cereb Cortex. 2000 Oct;10(10):1038-44. Review.

12.

Cerebral protein synthesis in a genetic mouse model of phenylketonuria.

Smith CB, Kang J.

Proc Natl Acad Sci U S A. 2000 Sep 26;97(20):11014-9.

13.

Role for rapid dendritic protein synthesis in hippocampal mGluR-dependent long-term depression.

Huber KM, Kayser MS, Bear MF.

Science. 2000 May 19;288(5469):1254-7.

14.

(Over)correction of FMR1 deficiency with YAC transgenics: behavioral and physical features.

Peier AM, McIlwain KL, Kenneson A, Warren ST, Paylor R, Nelson DL.

Hum Mol Genet. 2000 May 1;9(8):1145-59.

15.

Audiogenic seizures susceptibility in transgenic mice with fragile X syndrome.

Musumeci SA, Bosco P, Calabrese G, Bakker C, De Sarro GB, Elia M, Ferri R, Oostra BA.

Epilepsia. 2000 Jan;41(1):19-23.

16.

Fragile X mouse: strain effects of knockout phenotype and evidence suggesting deficient amygdala function.

Paradee W, Melikian HE, Rasmussen DL, Kenneson A, Conn PJ, Warren ST.

Neuroscience. 1999;94(1):185-92.

PMID:
10613508
17.
18.

Learning and memory in the FMR1 knockout mouse.

Fisch GS, Hao HK, Bakker C, Oostra BA.

Am J Med Genet. 1999 May 28;84(3):277-82.

PMID:
10331607
19.

Electrodermal responses to sensory stimuli in individuals with fragile X syndrome: a preliminary report.

Miller LJ, McIntosh DN, McGrath J, Shyu V, Lampe M, Taylor AK, Tassone F, Neitzel K, Stackhouse T, Hagerman RJ.

Am J Med Genet. 1999 Apr 2;83(4):268-79.

PMID:
10208160
Items per page

Supplemental Content

Support Center